Funder: Fanconi Cancer Foundation
Due Dates: March 6, 2026 (LOI deadline) | June 5, 2026 (Full proposal deadline)
Funding Amounts: $25,000–$250,000 per project for 1–2 years; milestone-based payments; no indirect costs
Summary: Supports innovative research on Fanconi anemia, emphasizing disease mechanisms, therapies, prevention, and quality of life.
Key Information: Preliminary data not required but strengthens applications; both preclinical and clinical projects eligible.